Ing Group, N.v. (IND) +0.1258

Trade IND
NOW!
Last Trade:20.3758Short Ratio:
Last Trade Time:4:00pmDay Range:20.26 - 20.50
Ask:Year Range:5.78 - 20.77
Bid:One Year Target:
Open:20.41Exchange:NYSE
Volume:31647EBITDA:0
Prev. Close:20.25Market Cap:
50 Day Moving:19.7278Div Yield:8.71
200 day moving:17.7599PE:

NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results

Posted on 03/12/10 at 8:06am
NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results PR Newswire ROCKVILLE, Md., March 12
Click here to read the rest of the article

Takara Bio to Enter into a Collaborative Research Agreement with University of Pennsylvania, Aiming for a Future Clinical Trial of HIV Gene Therapy

Posted on 03/12/10 at 7:30am
Tokyo, Mar 12, 2010 - (JCN Newswire) - Takara Bio Inc. announced today that it has executed a collaborative research agreement with University of Pennsylvania on March 11, 2010 to support an HIV gene therapy clinical trial in the United States. Under this agreement, Takara and Carl H.
Click here to read the rest of the article

Critical Outcome Technologies Inc. Reports Fiscal 2010 Third Quarter Financial Results

Posted on 03/10/10 at 9:33am
LONDON, ONTARIO--(Marketwire - March 10, 2010) - Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced fiscal 2010 third quarter financial results today for the three and nine month periods ended January 31, 2010.
Click here to read the rest of the article

Omeros Licenses PDE7 Compounds for Parkinson's Disease Program

Posted on 03/09/10 at 7:06am
Omeros Licenses PDE7 Compounds for Parkinson's Disease Program PR Newswire SEATTLE, March 9
Click here to read the rest of the article

Ricerca Biosciences Finalizes Acquisition of MDS Pharma Services Business

Posted on 03/08/10 at 9:42am
CONCORD, Ohio--(BUSINESS WIRE)-- Ricerca Biosciences, LLC, announced today the finalization of the acquisition of th
Click here to read the rest of the article

Generex Establishes Key Strategic Relationships for the Development of a Distribution Network for Generex Oral-lyn(R) Under the FDA's Expanded Access Treatment IND Program

Posted on 03/04/10 at 9:33am
WORCESTER, Mass., March 4, 2010 (GLOBE NEWSWIRE) -- In September of 2009, Generex Biotechnology Corporation (Nasdaq: GNBT) (
Click here to read the rest of the article

Santarus Reports Fourth Quarter and Full Year 2009 Financial Results

Posted on 03/03/10 at 4:12pm
SAN DIEGO--(BUSINESS WIRE)-- Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter and full year ended December 31, 2009. Key financial results for the 2009 fourth quarter:
Click here to read the rest of the article